Capricor Therapeutics CAPR
NASDAQ CAPR
$8.95 +0.01 (+0.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Capricor Therapeutics (CAPR) Cash from Discontinued Operations (2013 - 2014)

Updated

Capricor Therapeutics' Cash from Discontinued Operations was $933.00 in Q1 2014, down 99.9% from $857,267 a year earlier.

Analysis

Capricor Therapeutics (CAPR) Cash from Discontinued Operations (2013 - 2014) Analysis & Trends

For FY2013, Cash from Discontinued Operations at Capricor Therapeutics came in at $3.93 million, down 21.5% from FY2012.

  • In earlier years, Cash from Discontinued Operations was $5 million in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.87 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Capricor Therapeutics 520.08 Mn 520.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 933.00
Mar 31, 2013 857,267.00
API Access

Capricor Therapeutics Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=CAPR&period=max&api_key=YOUR_API_KEY